APA

Fuchs C. S., Tomasek J., Yong C. J., Dumitru F., Passalacqua R., Goswami C., Safran H., Dos Santos L. V., Aprile G., Ferry D. R., Melichar B., Tehfe M., Topuzov E., Zalcberg J. R., Chau I., Campbell W., Sivanandan C., Pikiel J., Koshiji M., Hsu Y., Liepa A. M., Gao L., Schwartz J. D. & Tabernero J. (20140123). Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. : Lancet (London, England).

Chicago

Fuchs Charles S, Tomasek Jiri, Yong Cho Jae, Dumitru Filip, Passalacqua Rodolfo, Goswami Chanchal, Safran Howard, Dos Santos Lucas Vieira, Aprile Giuseppe, Ferry David R, Melichar Bohuslav, Tehfe Mustapha, Topuzov Eldar, Zalcberg John Raymond, Chau Ian, Campbell William, Sivanandan Choondal, Pikiel Joanna, Koshiji Minori, Hsu Yanzhi, Liepa Astra M, Gao Ling, Schwartz Jonathan D and Tabernero Josep. 20140123. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. : Lancet (London, England).

Harvard

Fuchs C. S., Tomasek J., Yong C. J., Dumitru F., Passalacqua R., Goswami C., Safran H., Dos Santos L. V., Aprile G., Ferry D. R., Melichar B., Tehfe M., Topuzov E., Zalcberg J. R., Chau I., Campbell W., Sivanandan C., Pikiel J., Koshiji M., Hsu Y., Liepa A. M., Gao L., Schwartz J. D. and Tabernero J. (20140123). Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. : Lancet (London, England).

MLA

Fuchs Charles S, Tomasek Jiri, Yong Cho Jae, Dumitru Filip, Passalacqua Rodolfo, Goswami Chanchal, Safran Howard, Dos Santos Lucas Vieira, Aprile Giuseppe, Ferry David R, Melichar Bohuslav, Tehfe Mustapha, Topuzov Eldar, Zalcberg John Raymond, Chau Ian, Campbell William, Sivanandan Choondal, Pikiel Joanna, Koshiji Minori, Hsu Yanzhi, Liepa Astra M, Gao Ling, Schwartz Jonathan D and Tabernero Josep. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. : Lancet (London, England). 20140123.